Harrow HROW
NASDAQ HROW
$31.40 -0.20 (-0.63%)
At close: Sep 29, 2026 · 4:00 PM EDT

Harrow (HROW) EBITDA Margin (2013 - 2026)

Updated

Harrow (HROW) reported EBITDA Margin of -7.10% for Q2 2026, down 32.41 percentage points from 25.31% a year earlier but up 30.21 percentage points from the prior quarter.

Analysis

Harrow (HROW) EBITDA Margin (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Harrow's EBITDA Margin came in at 6.65%, down 7.17 percentage points year-over-year; for FY2025, it was 18.15%, up 6.90 percentage points from FY2024.

  • EBITDA Margin has increased for four consecutive years, with a five-year change of +13.17 percentage points (FY2020 to FY2025).
  • By year, EBITDA Margin came in at 11.25% in FY2024 (+2.00 pp), 9.25% in FY2023 (+3.64 pp), 5.61% in FY2022 (+0.80 pp) and 4.82% in FY2021 (-0.16 pp).
  • Five-year quarterly EBITDA Margin spans a low of -37.32% in Q1 2026 and a high of 27.17% in Q3 2025.
  • Year over year, EBITDA Margin has now declined in each of the last three quarters, with an average year-over-year change of -0.07 percentage points over the last eight quarters.
  • The high point for year-over-year EBITDA Margin in five years was Q4 2024 (a gain of 31.58 percentage points); the low point was Q2 2026 (a drop of 32.41 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -37.32% (Q1 2026), 22.86% (Q4 2025) and 27.17% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Harrow 1.18 Bn 858.40 Mn 50.36 Mn -7.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.10%
Mar 31, 2026 -37.32%
Dec 31, 2025 22.86%
Sep 30, 2025 27.17%
Jun 30, 2025 25.31%
Mar 31, 2025 -13.68%
Dec 31, 2024 26.10%
Sep 30, 2024 8.98%
Jun 30, 2024 9.26%
Mar 31, 2024 -11.40%
Dec 31, 2023 -5.48%
Sep 30, 2023 13.81%
Jun 30, 2023 16.71%
Mar 31, 2023 14.21%
Dec 31, 2022 -4.98%
Sep 30, 2022 2.41%
Jun 30, 2022 10.77%
Mar 31, 2022 13.22%
Dec 31, 2021 -6.31%
Sep 30, 2021 -17.50%
API Access

Harrow EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HROW&period=max&api_key=YOUR_API_KEY